ResearcherDalhousie UniversityActive in the last 2 years
Stacey N. Lee
Matched on ORCID iD 0000-0001-6518-8006; OpenAlex author ID A5067080778. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers
Papers 5
- Natural killer cell immunotherapy for pancreatic cancer: Release the brakes. Co-author DOI 10.1016/j.omton.2026.201223↗
- Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors and evades HLA I-driven inhibition. Co-author DOI 10.1136/jitc-2025-013796↗
- Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2025.1730817↗
- Canadian National Pancreas Conference 2023: A Review of Multidisciplinary Engagement in Pancreatic Cancer Care. Co-author DOI 10.3390/curroncol31100461↗
- PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical Pathology. Co-author DOI 10.3390/jcm11144241↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jeanette E. Boudreau · 4 shared papers, 2022–2026 · strength 1.44
- Paper Natural killer cell immunotherapy for pancreatic cancer: Release the brakes. DOI 10.1016/j.omton.2026.201223↗
- Paper Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors an… DOI 10.1136/jitc-2025-013796↗
- Paper Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma. DOI 10.3389/fimmu.2025.1730817↗
- Riley J. Arseneau · 3 shared papers, 2024–2026 · strength 0.83
- Paper Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors an… DOI 10.1136/jitc-2025-013796↗
- Paper Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma. DOI 10.3389/fimmu.2025.1730817↗
- Paper Canadian National Pancreas Conference 2023: A Review of Multidisciplinary Engagement in Pancreatic Cancer Care. DOI 10.3390/curroncol31100461↗
- Thomas Arnason · 3 shared papers, 2022–2026 · strength 0.81
- Paper Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors an… DOI 10.1136/jitc-2025-013796↗
- Paper Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma. DOI 10.3389/fimmu.2025.1730817↗
- Paper PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical Pathology. DOI 10.3390/jcm11144241↗
- Ravi Ramjeesingh · 2 shared papers, 2024–2025 · strength 0.40
- Boris Gala-López · 2 shared papers, 2024–2025 · strength 0.40
- Thomas Samson · 1 shared paper, 2025 · strength 0.24
- Carley Bekkers · 1 shared paper, 2025 · strength 0.24
- Chloe Cyr · 1 shared paper, 2024 · strength 0.16
- Masoom A. Haider · 1 shared paper, 2024 · strength 0.16
- Keith John Roberts · 1 shared paper, 2024 · strength 0.16
- Sharlene Gill · 1 shared paper, 2024 · strength 0.16
- Christina Kim · 1 shared paper, 2024 · strength 0.16
- Jessica L. Nickerson · 1 shared paper, 2024 · strength 0.16
- Sylvia S. W. Ng · 1 shared paper, 2024 · strength 0.16
- Erica S. Tsang · 1 shared paper, 2024 · strength 0.16
- George Zogopoulos · 1 shared paper, 2024 · strength 0.16
- Ryan C. DeCoste · 1 shared paper, 2022 · strength 0.14
- Weei‐Yuarn Huang · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.